Frequently Used Allopathic and Traditional Medicine for COVID-19 Treatment and Feasibility of Their Integration.
10.1007/s11655-021-3512-5
- Author:
Aditya UPADHAYAY
1
;
Gopal PATEL
2
;
Dharm PAL
3
;
Awanish KUMAR
4
Author Information
1. Department of Biotechnology, National Institute of Technology, Raipur, CG, 492010, India.
2. Laboratory of Medicinal Plant Biotechnology, College of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, 310053, China.
3. Department of Chemical Engineering, National Institute of Technology, Raipur, CG, 492010, India.
4. Department of Biotechnology, National Institute of Technology, Raipur, CG, 492010, India. drawanishkr@gmail.com.
- Publication Type:Review
- Keywords:
COVID-19;
allopathy;
integration;
promising therapy;
traditional medicine
- MeSH:
Humans;
Feasibility Studies;
Pandemics;
Medicine, Traditional;
COVID-19 Drug Treatment
- From:Chinese journal of integrative medicine
2022;28(11):1040-1047
- CountryChina
- Language:English
-
Abstract:
To date, no satisfactory treatment for COVID-19 is available. This review reported few recent updates regarding the drugs (allopathy/traditional medicines) used for the treatment of COVID-19 concerning clinical studies. Content of the article spotlight the contribution of allopathic and Ayurvedic drugs to the scientific basis for utilization as a potential therapy against COVID-19 infection and provide new insights on the integration of allopathy and traditional medicine. It advocated the combination of these two systems of treatment will ascertain their integrations, and there would be a good possibility and scope for developing a model of integration in the management of COVID-19. Provided discussion may help researchers, physicians, and healthcare policymakers to encourage for effective and integrated use of allopathic and Ayurvedic medicines to control the COVID-19 pandemic more effectively.
